Mast cells and influenza A virus: Association with allergic responses and beyond

Frontiers in Immunology

Volumn 6, Issue MAY, 2015, Pages

  Graham, Amy C ^a   Temple, Rachel M ^a   Obar, Joshua J ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

Degranulation; Dengue virus; Inflammation; Influenza A virus; Mast cell; Mast cell activation; Viral immunology; Viral infection

Indexed keywords

C TYPE LECTIN RECEPTOR; CARRIER PROTEINS AND BINDING PROTEINS; CD48 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CYTOKINE; FC RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEMAGGLUTININ; HISTAMINE; INTEGRIN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOTRIENE; LEUKOTRIENE B4; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PROSTAGLANDIN E2; PROTEINASE; RETINOIC ACID INDUCIBLE GENE 1 LIKE RECEPTOR; SIALIDASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ALLERGIC REACTION; ALLERGY; ASTHMA; BACTERIAL INFECTION; BIRD; CELL ACTIVATION; CELL DIVISION; CYTOLOGY; DENDRITIC CELL; DENGUE VIRUS; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; HANTAVIRUS; HUMAN; IMMUNOPATHOLOGY; INFECTIOUS BURSAL DISEASE VIRUS; INFLAMMATION; INFLUENZA A; INFLUENZA VIRUS A; LUNG ALVEOLUS EPITHELIUM CELL; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; MAMMAL; MAST CELL; MORBIDITY; MORTALITY; NEWCASTLE DISEASE VIRUS; NONHUMAN; PANDEMIC; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; REVIEW; SENDAI VIRUS; VIRUS ENTRY; VIRUS PARTICLE; ZOONOSIS;

EID: 84934298712     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00238     Document Type: Review

References (158)

1. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol (2008) 3:499-522. doi: 10.1146/annurev.pathmechdis.3.121806.154316
2. Webster RG, Govorkova EA. Continuing challenges in influenza. Ann N Y Acad Sci (2014) 1323:115-39. doi:10.1111/nyas.12462
3. Jernigan DB, Cox NJ. H7N9: preparing for the unexpected in influenza. Annu Rev Med (2015) 66:361-71. doi:10.1146/annurev-med-010714-112311
4. Fouchier RA, Kawaoka Y, Cardona C, Compans RW, Fouchier RA, Garcia-Sastre A, et al. Avian flu: gain-of-function experiments on H7N9. Nature (2013) 500(7461):150-1. doi:10.1038/500150a
5. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 486(7403):420-8. doi:10.1038/nature10831
6. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. The molecular basis of the specific anti-influenza action of amantadine. EMBO J (1985) 4(11):3021-4.
7. Stiver G. The treatment of influenza with antiviral drugs. CMAJ (2003) 168(1):49-56.
8. Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, Paulshock M, et al. Antiviral activity of 1-adamantanamine (amantadine). Science (1964) 144(3620):862-3. doi:10.1126/science.144.3620.862
9. Wathen MW, Barro M, Bright RA. Antivirals in seasonal and pandemic influenza-future perspectives. Influenza Other Respi Viruses (2013) 7(Suppl 1):76-80. doi:10.1111/irv.12049
10. Samson M, Pizzorno A, Abed Y, Boivin G. Influenza virus resistance to neuraminidase inhibitors. Antiviral Res (2013) 98(2):174-85. doi:10.1016/j.antiviral.2013.03.014
11. Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science (2010) 328(5983):1272-5. doi:10.1126/science.1187816
12. Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis (2012) 18(2):308-11. doi:10.3201/eid1802.111466
13. Vale PF, Fenton A, Brown SP. Limiting damage during infection: lessons from infection tolerance for novel therapeutics. PLoS Biol (2014) 12(1):e1001769. doi:10.1371/journal.pbio.1001769
14. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science (2012) 335(6071):936-41. doi:10.1126/science.1214935
15. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, Swayne DE, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 310(5745):77-80. doi:10.1126/science.1119392
16. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog (2008) 4(8):e1000115. doi:10.1371/journal.ppat.1000115
17. Brandes M, Klauschen F, Kuchen S, Germain RN. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell (2013) 154(1):197-212. doi:10.1016/j.cell.2013.06.013
18. Tolnay AE, Baskin CR, Tumpey TM, Sabourin PJ, Sabourin CL, Long JP, et al. Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus. Arch Virol (2010) 155(6):905-14. doi:10.1007/s00705-010-0662-8
19. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 443(7111):578-81. doi:10.1038/nature05181
20. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, Zaki SR, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol (2007) 81(6):2736-44. doi:10.1128/JVI.02336-06
21. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell (2011) 146(6):980-91. doi:10.1016/j.cell.2011.08.015
22. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, Garcia-Sastre A, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A (2009) 106(9):3455-60. doi:10.1073/pnas.0813234106
23. Graham AC, Hilmer KM, Zickovich JM, Obar JJ. Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling. J Immunol (2013) 190(9):4676-84. doi:10.4049/jimmunol.1202096
24. Hu Y, Jin Y, Han D, Zhang G, Cao S, Xie J, et al. Mast cell-induced lung injury in mice infected with H5N1 influenza virus. J Virol (2012) 86(6):3347-56. doi:10.1128/JVI.06053-11
25. Liu B, Meng D, Wei T, Zhang S, Hu Y, Wang M. Apoptosis and pro-inflammatory cytokine response of mast cells induced by influenza A viruses. PLoS One (2014) 9(6):e100109. doi:10.1371/journal.pone.0100109
26. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol (2005) 23:749-86. doi:10.1146/annurev.immunol.21.120601.141025
27. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol (2010) 10(6):440-52. doi:10.1038/nri2782
28. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol (2004) 114(1):21-7. doi:10.1016/j.jaci.2004.04.045
29. Sayed BA, Christy A, Quirion MR, Brown MA. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol (2008) 26:705-39. doi:10.1146/annurev.immunol.26.021607.090320
30. Metz M, Maurer M. Mast cells-key effector cells in immune responses. Trends Immunol (2007) 28(5):234-41. doi:10.1016/j.it.2007.03.003
31. Wang Z, Lai Y, Bernard JJ, Macleod DT, Cogen AL, Moss B, et al. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides. J Immunol (2012) 188(1):345-57. doi:10.4049/jimmunol.1101703
32. Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nat Rev Immunol (2014) 14(7):478-94. doi:10.1038/nri3690
33. Gurish MF, Austen KF. Developmental origin and functional specialization of mast cell subsets. Immunity (2012) 37(1):25-33. doi:10.1016/j.immuni.2012.07.003
34. Kunder CA, St John AL, Li G, Leong KW, Berwin B, Staats HF, et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med (2009) 206(11):2455-67. doi:10.1084/jem.20090805
35. St John AL, Chan CY, Staats HF, Leong KW, Abraham SN. Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. Nat Mater (2012) 11(3):250-7. doi:10.1038/nmat3222
36. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A (2010) 107(25):11531-6. doi:10.1073/pnas.0914994107
37. Thakurdas SM, Melicoff E, Sansores-Garcia L, Moreira DC, Petrova Y, Stevens RL, et al. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J Biol Chem (2007) 282(29):20809-15. doi:10.1074/jbc. M611842200
38. Tani K, Ogushi F, Kido H, Kawano T, Kunori Y, Kamimura T, et al. Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol (2000) 67(4):585-9.
39. Huang C, Friend DS, Qiu WT, Wong GW, Morales G, Hunt J, et al. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J Immunol (1998) 160(4):1910-9.
40. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature (2004) 432(7016):512-6. doi:10.1038/nature03085
41. Piliponsky AM, Chen CC, Nishimura T, Metz M, Rios EJ, Dobner PR, et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med (2008) 14(4):392-8. doi:10.1038/nm1738
42. Metz M, Piliponsky AM, Chen CC, Lammel V, Abrink M, Pejler G, et al. Mast cells can enhance resistance to snake and honeybee venoms. Science (2006) 313(5786):526-30. doi:10.1126/science.1128877
43. Akahoshi M, Song CH, Piliponsky AM, Metz M, Guzzetta A, Abrink M, et al. Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. J Clin Invest (2011) 121(10):4180-91. doi:10.1172/JCI46139
44. Ghildyal N, McNeil HP, Gurish MF, Austen KF, Stevens RL. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Chem (1992) 267(12):8473-7.
45. Toru H, Pawankar R, Ra C, Yata J, Nakahata T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol (1998) 102(3):491-502. doi:10.1016/S0091-6749(98)70140-X
46. Burwen SJ. Recycling of mast cells following degranulation in vitro: an ultrastructural study. Tissue Cell (1982) 14(1):125-34. doi:10.1016/0040-8166(82)90012-X
47. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev (1997) 77(4):1033-79.
48. Boyce JA. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol Rev (2007) 217:168-85. doi:10.1111/j.1600-065X.2007.00512.x
49. Malaviya R, Abraham SN. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol (2000) 67(6):841-6.
50. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (2001) 294(5548):1871-5. doi:10.1126/science.294.5548.1871
51. Kunder CA, St John AL, Abraham SN. Mast cell modulation of the vascular and lymphatic endothelium. Blood (2011) 118(20):5383-93. doi:10.1182/blood-2011-07-358432
52. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med (2012) 18(5):693-704. doi:10.1038/nm.2755
53. Dahlin JS, Hallgren J. Mast cell progenitors: origin, development and migration to tissues. Mol Immunol (2015) 63(1):9-17. doi:10.1016/j.molimm.2014.01.018
54. Bankova LG, Dwyer DF, Liu AY, Austen KF, Gurish MF. Maturation of mast cell progenitors to mucosal mast cells during allergic pulmonary inflammation in mice. Mucosal Immunol (2015) 8(3):596-606. doi:10.1038/mi.2014.91
55. Abonia JP, Hallgren J, Jones T, Shi T, Xu Y, Koni P, et al. Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung. Blood (2006) 108(5):1588-94. doi:10.1182/blood-2005-12-012781
56. Hallgren J, Jones TG, Abonia JP, Xing W, Humbles A, Austen KF, et al. Pulmonary CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast cell progenitors. Proc Natl Acad Sci U S A (2007) 104(51):20478-83. doi:10.1073/pnas.0709651104
57. Jones TG, Hallgren J, Humbles A, Burwell T, Finkelman FD, Alcaide P, et al. Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J Immunol (2009) 183(8):5251-60. doi:10.4049/jimmunol.0901471
58. Weller CL, Collington SJ, Brown JK, Miller HR, Al-Kashi A, Clark P, et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med (2005) 201(12):1961-71. doi:10.1084/jem.20042407
59. Metcalf D, Majewski I, Mifsud S, Di Rago L, Alexander WS. Clonogenic mast cell progenitors and their excess numbers in chimeric BALB/c mice with inactivated GATA-1. Proc Natl Acad Sci U S A (2007) 104(47):18642-7. doi:10.1073/pnas.0709625104
60. Liu AY, Dwyer DF, Jones TG, Bankova LG, Shen S, Katz HR, et al. Mast cells recruited to mesenteric lymph nodes during helminth infection remain hypogranular and produce IL-4 and IL-6. J Immunol (2013) 190(4):1758-66. doi:10.4049/jimmunol.1202567
61. Sorden SD, Castleman WL. Virus-induced increases in bronchiolar mast cells in brown Norway rats are associated with both local mast cell proliferation and increases in blood mast cell precursors. Lab Invest (1995) 73(2):197-204.
62. Sun Q, Li W, She R, Wang D, Han D, Li R, et al. Evidence for a role of mast cells in the mucosal injury induced by Newcastle disease virus. Poult Sci (2009) 88(3):554-61. doi:10.3382/ps.2008-00468
63. Sun Q, Wang D, She R, Li W, Liu S, Han D, et al. Increased mast cell density during the infection with velogenic Newcastle disease virus in chickens. Avian Pathol (2008) 37(6):579-85. doi:10.1080/03079450802499092
64. Wang D, Xiong J, She R, Liu L, Zhang Y, Luo D, et al. Mast cell mediated inflammatory response in chickens after infection with very virulent infectious bursal disease virus. Vet Immunol Immunopathol (2008) 124(1-2):19-28. doi:10.1016/j.vetimm.2008.01.005
65. Wang D, Zhou X, She R, Xiong J, Sun Q, Peng K, et al. Impaired intestinal mucosal immunity in specific-pathogen-free chickens after infection with very virulent infectious bursal disease virus. Poult Sci (2009) 88(8):1623-8. doi:10.3382/ps.2009-00124
66. Castleman WL, Sorkness RL, Lemanske RF Jr, McAllister PK. Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells and airway hyperresponsiveness. Am J Pathol (1990) 137(4):821-31.
67. Beaven MA, Metzger H. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol Today (1993) 14(5):222-6. doi:10.1016/0167-5699(93)90167-J
68. Thomas PG, Dash P, Aldridge JR Jr, Ellebedy AH, Reynolds C, Funk AJ, et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity (2009) 30(4):566-75. doi:10.1016/j.immuni.2009.02.006
69. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity (2009) 30(4):556-65. doi:10.1016/j.immuni.2009.02.005
70. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, et al. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol (2007) 178(6):3368-72. doi:10.4049/jimmunol.178.6.3368
71. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, et al. Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc Natl Acad Sci U S A (2004) 101(15):5598-603. doi:10.1073/pnas.0400937101
72. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (2004) 303(5663):1529-31. doi:10.1126/science.1093616
73. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science (2006) 314(5801):997-1001. doi:10.1126/science.1132998
74. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity (2005) 23(1):19-28. doi:10.1016/j.immuni.2005.04.010
75. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 122(5):669-82. doi:10.1016/j.cell.2005.08.012
76. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol (2005) 6(10):981-8. doi:10.1038/ni1243
77. Heib V, Becker M, Warger T, Rechtsteiner G, Tertilt C, Klein M, et al. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood (2007) 110(3):946-53. doi:10.1182/blood-2006-07-036889
78. Nakamura Y, Kambe N, Saito M, Nishikomori R, Kim YG, Murakami M, et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med (2009) 206(5):1037-46. doi:10.1084/jem.20082179
79. Orinska Z, Bulanova E, Budagian V, Metz M, Maurer M, Bulfone-Paus S. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood (2005) 106(3):978-87. doi:10.1182/blood-2004-07-2656
80. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 441(7089):101-5. doi:10.1038/nature04734
81. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med (2009) 206(1):79-87. doi:10.1084/jem.20081667
82. St John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, Vasudevan SG, et al. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A (2011) 108(22):9190-5. doi:10.1073/pnas.1105079108
83. Rocha-de-Souza CM, Berent-Maoz B, Mankuta D, Moses AE, Levi-Schaffer F. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of toll-like receptor 2 and CD48 molecules. Infect Immun (2008) 76(10):4489-97. doi:10.1128/IAI.00270-08
84. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature (1996) 381(6577):77-80. doi:10.1038/381077a0
85. Edelson BT, Li Z, Pappan LK, Zutter MM. Mast cell-mediated inflammatory responses require the alpha 2 beta 1 integrin. Blood (2004) 103(6):2214-20. doi:10.1182/blood-2003-08-2978
86. Rao KN, Brown MA. Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann N Y Acad Sci (2008) 1143:83-104. doi:10.1196/annals.1443.023
87. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by toll-like receptor 4. J Immunol (2001) 167(4):2250-6. doi:10.4049/jimmunol.167.4.2250
88. Saitoh S, Odom S, Gomez G, Sommers CL, Young HA, Rivera J, et al. The four distal tyrosines are required for LAT-dependent signaling in FcepsilonRI-mediated mast cell activation. J Exp Med (2003) 198(5):831-43. doi:10.1084/jem.20030574
89. Ozawa K, Yamada K, Kazanietz MG, Blumberg PM, Beaven MA. Different isozymes of protein kinase C mediate feedback inhibition of phospholipase C and stimulatory signals for exocytosis in rat RBL-2H3 cells. J Biol Chem (1993) 268(4):2280-3.
90. Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E, Roomans GM, et al. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med (2000) 162(6):2295-301. doi:10.1164/ajrccm.162.6.9912001
91. Djukanovic R, Lai CK, Wilson JW, Britten KM, Wilson SJ, Roche WR, et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J (1992) 5(5):538-44.
92. Minor TE, Dick EC, Baker JW, Ouellette JJ, Cohen M, Reed CE. Rhinovirus and influenza type A infections as precipitants of asthma. Am Rev Respir Dis (1976) 113(2):149-53.
93. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 310(6989):1225-9. doi:10.1136/bmj.310.6989.1225
94. Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy (1992) 22(3):325-36. doi:10.1111/j.1365-2222.1992.tb03094.x
95. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ (1993) 307(6910):982-6. doi:10.1136/bmj.307.6910.982
96. Arruda E, Pitkaranta A, Witek TJ Jr, Doyle CA, Hayden FG. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol (1997) 35(11):2864-8.
97. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 154(3 Pt 1):654-60. doi:10.1164/ajrccm.154.3.8810601
98. Obuchi M, Adachi Y, Takizawa T, Sata T. Influenza A(H1N1)pdm09 virus and asthma. Front Microbiol (2013) 4:307. doi:10.3389/fmicb.2013.00307
99. Kloepfer KM, Olenec JP, Lee WM, Liu G, Vrtis RF, Roberg KA, et al. Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med (2012) 185(12):1275-9. doi:10.1164/rccm.201109-1635OC
100. McKenna JJ, Bramley AM, Skarbinski J, Fry AM, Finelli L, Jain S, et al. Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009. BMC Infect Dis (2013) 13:57. doi:10.1186/1471-2334-13-57
101. Hasegawa S, Hirano R, Hashimoto K, Haneda Y, Shirabe K, Ichiyama T. Characteristics of atopic children with pandemic H1N1 influenza viral infection: pandemic H1N1 influenza reveals 'occult' asthma of childhood. Pediatr Allergy Immunol (2011) 22(1 Pt 2):e119-23. doi:10.1111/j.1399-3038.2010.01090.x
102. Yamaya M. Virus infection-induced bronchial asthma exacerbation. Pulm Med (2012) 2012:834826. doi:10.1155/2012/834826
103. St John AL, Rathore AP, Raghavan B, Ng ML, Abraham SN. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife (2013) 2:e00481. doi:10.7554/eLife.00481
104. Short KR, Kroeze EJ, Fouchier RA, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis (2014) 14(1):57-69. doi:10.1016/S1473-3099(13)70286-X
105. Boonnak K, Vogel L, Feldmann F, Feldmann H, Legge KL, Subbarao K. Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells. J Immunol (2014) 192(12):5906-12. doi:10.4049/jimmunol.1302992
106. Li C, Li C, Zhang AJ, To KK, Lee AC, Zhu H, et al. Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor. PLoS One (2014) 9(9):e107966. doi:10.1371/journal.pone.0107966
107. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature (2013) 501(7468):556-9. doi:10.1038/nature12391
108. Josset L, Belser JA, Pantin-Jackwood MJ, Chang JH, Chang ST, Belisle SE, et al. Implication of inflammatory macrophages, nuclear receptors, and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation. J Virol (2012) 86(13):7192-206. doi:10.1128/JVI.00563-12
109. Gentile DA, Doyle WJ, Fireman P, Skoner DP. Effect of experimental influenza A infection on systemic immune and inflammatory parameters in allergic and nonallergic adult subjects. Ann Allergy Asthma Immunol (2001) 87(6):496-500. doi:10.1016/S1081-1206(10)62263-6
110. Skoner DP, Gentile DA, Fireman P, Cordoro K, Doyle WJ. Urinary histamine metabolite elevations during experimental influenza infection. Ann Allergy Asthma Immunol (2001) 87(4):303-6. doi:10.1016/S1081-1206(10)62244-2
111. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, et al. Adaptation of pandemic H1N1 influenza viruses in mice. J Virol (2010) 84(17):8607-16. doi:10.1128/JVI.00159-10
112. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol (2005) 167(3):835-48. doi:10.1016/S0002-9440(10)62055-X
113. Halstead SB. Dengue. Lancet (2007) 370(9599):1644-52. doi:10.1016/S0140-6736(07)61687-0
114. Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology (1999) 257(1):1-6. doi:10.1006/viro.1999.9656
115. Bhamarapravati N, Tuchinda P, Boonyapaknavik V. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol (1967) 61(4):500-10.
116. Phan DT, Ha NT, Thuc LT, Diet NH, Phu LV, Ninh LY, et al. Some changes in immunity and blood in relation to clinical states of dengue hemorrhagic fever patients in Vietnam. Haematologia (1991) 24(1):13-21.
117. Vitarana T, de Silva H, Withana N, Gunasekera C. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med J (1991) 36(2):63-5.
118. Tseng CS, Lo HW, Teng HC, Lo WC, Ker CG. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol (2005) 43(1):99-102. doi:10.1016/j.femsim.2004.10.004
119. King CA, Anderson R, Marshall JS. Dengue virus selectively induces human mast cell chemokine production. J Virol (2002) 76(16):8408-19. doi:10.1128/JVI.76.16.8408-8419.2002
120. Sanchez LF, Hotta H, Hotta S, Homma M. Degranulation and histamine release from murine mast cells sensitized with dengue virus-immune sera. Microbiol Immunol (1986) 30(8):753-9. doi:10.1111/j.1348-0421.1986.tb03002.x
121. Brown MG, Hermann LL, Issekutz AC, Marshall JS, Rowter D, Al-Afif A, et al. Dengue virus infection of mast cells triggers endothelial cell activation. J Virol (2011) 85(2):1145-50. doi:10.1128/JVI.01630-10
122. Salmi M, Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol (2005) 5(10):760-71. doi:10.1038/nri1705
123. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol (2008) 9(5):503-10. doi:10.1038/ni1582
124. Syenina A, Jagaraj CJ, Aman SA, Sridharan A, St John AL. Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcgamma receptors. Elife (2015) 4:e05291. doi:10.7554/eLife.05291
125. Guhl S, Franke R, Schielke A, Johne R, Kruger DH, Babina M, et al. Infection of in vivo differentiated human mast cells with hantaviruses. J Gen Virol (2010) 91(Pt 5):1256-61. doi:10.1099/vir.0.019505-0
126. Raftery MJ, Kraus AA, Ulrich R, Kruger DH, Schonrich G. Hantavirus infection of dendritic cells. J Virol (2002) 76(21):10724-33. doi:10.1128/JVI.76.21.10724-10733.2002
127. Zaki SR, Khan AS, Goodman RA, Armstrong LR, Greer PW, Coffield LM, et al. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. Arch Pathol Lab Med (1996) 120(2):134-9.
128. Sorkness R, Lemanske RF Jr, Castleman WL. Persistent airway hyperresponsiveness after neonatal viral bronchiolitis in rats. J Appl Physiol (1991) 70(1):375-83.
129. Sorden SD, Castleman WL. Brown Norway rats are high responders to bronchiolitis, pneumonia, and bronchiolar mastocytosis induced by parainfluenza virus. Exp Lung Res (1991) 17(6):1025-45. doi:10.3109/01902149109064333
130. Sorden SD, Castleman WL. Virus-induced increases in airway mast cells in brown Norway rats are associated with enhanced pulmonary viral replication and persisting lymphocytic infiltration. Exp Lung Res (1995) 21(2):197-213. doi:10.3109/01902149509068827
131. Lappalainen J, Rintahaka J, Kovanen PT, Matikainen S, Eklund KK. Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells. Clin Exp Immunol (2013) 172(1):121-8. doi:10.1111/cei.12042
132. Sugiyama K. Histamine release from rat mast cells induced by Sendai virus. Nature (1977) 270(5638):614-5. doi:10.1038/270614a0
133. Chen Y, Shiota M, Ohuchi M, Towatari T, Tashiro J, Murakami M, et al. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization. Eur J Biochem (2000) 267(11):3189-97. doi:10.1046/j.1432-1327.2000.01346.x
134. Miller EK, Hernandez JZ, Wimmenauer V, Shepherd BE, Hijano D, Libster R, et al. A mechanistic role for type III IFN-lambda1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med (2012) 185(5):508-16. doi:10.1164/rccm.201108-1462OC
135. Jungmann A, Nieper H, Muller H. Apoptosis is induced by infectious bursal disease virus replication in productively infected cells as well as in antigen-negative cells in their vicinity. J Gen Virol (2001) 82(Pt 5):1107-15.
136. Vasconcelos AC, Lam KM. Apoptosis in chicken embryos induced by the infectious bursal disease virus. J Comp Pathol (1995) 112(4):327-38. doi:10.1016/S0021-9975(05)80014-3
137. Khatri M, Palmquist JM, Cha RM, Sharma JM. Infection and activation of bursal macrophages by virulent infectious bursal disease virus. Virus Res (2005) 113(1):44-50. doi:10.1016/j.virusres.2005.04.014
138. Leslie J. Newcastle disease: outbreak losses and control policy costs. Vet Rec (2000) 146(21):603-6. doi:10.1136/vr.146.21.603
139. Li Y, Wang X, Bo K, Wang X, Tang B, Yang B, et al. Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China. Vet J (2007) 174(3):577-84. doi:10.1016/j.tvjl.2007.07.032
140. Tian ZJ, An TQ, Zhou YJ, Peng JM, Hu SP, Wei TC, et al. An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRS. Vet Microbiol (2009) 138(1-2):34-40. doi:10.1016/j.vetmic.2009.03.003
141. Han D, Hu Y, Li L, Tian H, Chen Z, Wang L, et al. Highly pathogenic porcine reproductive and respiratory syndrome virus infection results in acute lung injury of the infected pigs. Vet Microbiol (2014) 169(3-4):135-46. doi:10.1016/j.vetmic.2013.12.022
142. Al-Afif A, Alyazidi R, Oldford SA, Huang YY, King CA, Haidl ID, et al. Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4. J Allergy Clin Immunol (2015). doi:10.1016/j.jaci.2015.01.042
143. Tate MD, Pickett DL, van Rooijen N, Brooks AG, Reading PC. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol (2010) 84(15):7569-80. doi:10.1128/JVI.00291-10
144. Smed-Sorensen A, Chalouni C, Chatterjee B, Cohn L, Blattmann P, Nakamura N, et al. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog (2012) 8(3):e1002572. doi:10.1371/journal.ppat.1002572
145. Marcet CW, St Laurent CD, Moon TC, Singh N, Befus AD. Limited replication of influenza A virus in human mast cells. Immunol Res (2013) 56(1):32-43. doi:10.1007/s12026-012-8377-4
146. Fukuda M, Ushio H, Kawasaki J, Niyonsaba F, Takeuchi M, Baba T, et al. Expression and functional characterization of retinoic acid-inducible gene-I-like receptors of mast cells in response to viral infection. J Innate Immun (2013) 5(2):163-73. doi:10.1159/000343895
147. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through toll-like receptor 3. J Allergy Clin Immunol (2004) 114(1):174-82. doi:10.1016/j.jaci.2004.03.049
148. Tsutsui-Takeuchi M, Ushio H, Fukuda M, Yamada T, Niyonsaba F, Okumura K, et al. Roles of retinoic acid-inducible gene-I-like receptors (RLRs), toll-like receptor (TLR) 3 and 2'-5' oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection. Immunol Res (2015) 61(3):240-9. doi:10.1007/s12026-014-8617-x
149. Aoki R, Kawamura T, Goshima F, Ogawa Y, Nakae S, Nakao A, et al. Mast cells play a key role in host defense against herpes simplex virus infection through TNF-alpha and IL-6 production. J Invest Dermatol (2013) 133(9):2170-9. doi:10.1038/jid.2013.150
150. Cluett EB, Kuismanen E, Machamer CE. Heterogeneous distribution of the unusual phospholipid semilysobisphosphatidic acid through the Golgi complex. Mol Biol Cell (1997) 8(11):2233-40. doi:10.1091/mbc.8.11.2233
151. Olivera A, Mizugishi K, Tikhonova A, Ciaccia L, Odom S, Proia RL, et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity (2007) 26(3):287-97. doi:10.1016/j.immuni.2007.02.008
152. Oskeritzian CA, Price MM, Hait NC, Kapitonov D, Falanga YT, Morales JK, et al. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J Exp Med (2010) 207(3):465-74. doi:10.1084/jem.20091513
153. Rivera J, Proia RL, Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol (2008) 8(10):753-63. doi:10.1038/nri2400
154. Domenico J, Lucas JJ, Fujita M, Gelfand EW. Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status. Int Arch Allergy Immunol (2012) 158(2):196-205. doi:10.1159/000330647
155. McClean SP, Arreaza EE, Lett-Brown MA, Grant JA. Refractory cholinergic urticaria successfully treated with ketotifen. J Allergy Clin Immunol (1989) 83(4):738-41. doi:10.1016/0091-6749(89)90008-0
156. Clementsen P, Hannoun C, Norn S. Influenza A virus enhances allergic histamine release. Effect of neuraminidase. Allergy (1989) 44(1):33-8. doi:10.1111/j.1398-9995.1989.tb00443.x
157. Clementsen P, Pedersen M, Permin H, Espersen F, Jarlov JO, Norn S. Virus enhances IgE-and non-IgE-dependent histamine release induced by bacteria and other stimulators. Agents Actions (1990) 30(1-2):61-3. doi:10.1007/BF01968998
158. Clementsen P, Pedersen M, Permin H, Espersen F, Norn S. Influenza A virus potentiates bacteria-induced histamine release. Examination of normal individuals and patients allergic to bacteria. Allergy (1990) 45(6):464-70. doi:10.1111/j.1398-9995.1990.tb01098.x